Thomas O’Dorisio, MD
Professor of Medicine, Director of the Neuroendocrine Tumor Clinics Program
Dr. Thomas O’Dorisio is Professor of Medicine and Director of the Neuroendocrine Tumor Clinics Program in the Holden Comprehensive Cancer Center at the University of Iowa. Currently 1700 patients with carcinoid and familial/sporadic neuroendocrine tumors in both children and adults are registered via an IRB approved consent form. With Co-directors Dr. James R. Howe (Endocrine surgeon) and Dr. M. Sue O’Dorisio (Pediatric Oncology), there are seven dedicated multi-disciplinary neuroendocrine tumor clinics weekly that include a neuroendocrine tumor clinic for the Veterans Administration Hospital. Multi- diagnostic and therapeutic modalities for these patients include the highly sensitive and specific 68-Gallium – DOTATOC PET scan. We are currently analyzing the safety and efficacy data of 200 subjects who have had this scan. Therapeutic advances include the registration trial of LU-177 –DOTA-Octretoate therapy, a multi-international institution protocol for progressive midgut carcinoid tumors. We anticipate the first peptide receptor radio-nuclide therapy (PRRNT) Phase II trial in the United States with Y90-DOTA-(tyr)-Octreotide within the next two months. We see between 16 and 24 new neuroendocrine patients monthly, and have 900-1200 neuroendocrine patient visits per year. Our Clinical-Clinical Research Center is modeled after the 21 or so European NET Centers of Excellence, dedicated to this rare cancer with a prevalence in the United States of about 110,000 patients and an incidence since 1989 that has risen by 500%.
To see his official University of Iowa Heath Care video profile, please click here.
BS, Regis College, Denver, Colorado
MS, Anatomy, Creighton University, Omaha, Nebraska
MD, Creighton University, Omaha, Nebraska
Internship, Internal Medicine, Creighton University
Residency, Internal Medicine, The Ohio State University, Columbus, Ohio
Fellowship, Endocrinology, The Ohio State University, Columbus, Ohio
Licensure and Certifications:
Medical License, Iowa Board of Medicine
Certification, The College of American Pathologists (CAP) Ohio
Certification of Accreditation, Department of Health & Human Services Health Care Financing Administration (HCFA) CLIA Laboratory
Certification, American Board of Internal Medicine
To make an appointment as a NEW patient, please call:
The Holden Comprehensive Cancer Center at the University of Iowa (319) 356-4200 Option #3, Ask for Molly Becker
University of Iowa Hospitals and Clinics 200 Hawkins Drive Iowa City, IA 52242 (800) 777-8442
Dr. O’Dorisio at the 2016 National NET Patient Conference:
Topic: PRRT Trials in America: What’s New?
When: Friday, September 23rd, 2016 at 1PM*
Be sure not to miss Dr. O’Dorisio speak! And don’t miss him on our panel answering your questions!!
For more information on Dr. O’Dorisio and the Holden Comprehensive Cancer Center at the University of Iowa, please visit their website here.
SIGN UP NOW FOR THE 2016 NATIONAL NET PATIENT CONFERENCE in New Orleans, LA from September 22-24th to see Dr. O’Dorisio and 19 other experts speak on Neuroendocrine Cancer!
Registration is $125 per person including
- Thursday’s Welcome Reception
- Breakfast, Lunch, and snacks for both Friday and Saturday
- And keep your eyes out for some special prizes!
Registration does not include your hotel stay or travel expenses.
For more information and to buy your ticket, click here!!
*Time and Date are subject to change.